BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17493349)

  • 1. [Induction of tolerogenic dendritic cells by membrane-bound HLA-G in vitro].
    Zhou H; Li WM; Zhang M; Liu ZR; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):369-72. PubMed ID: 17493349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
    Gregori S; Tomasoni D; Pacciani V; Scirpoli M; Battaglia M; Magnani CF; Hauben E; Roncarolo MG
    Blood; 2010 Aug; 116(6):935-44. PubMed ID: 20448110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerization of dendritic cells by HLA-G.
    Ristich V; Liang S; Zhang W; Wu J; Horuzsko A
    Eur J Immunol; 2005 Apr; 35(4):1133-42. PubMed ID: 15770701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-G-treated tolerogenic dendritic cells induce tolerogenic potential by increasing expression of B7-1 (CD80) molecules.
    Smith M; Bittner JG; White S; Smith D; Horuzsko A
    Transplant Proc; 2008 Jun; 40(5):1598-603. PubMed ID: 18589158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells.
    Brenk M; Scheler M; Koch S; Neumann J; Takikawa O; Häcker G; Bieber T; von Bubnoff D
    J Immunol; 2009 Jul; 183(1):145-54. PubMed ID: 19535644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction.
    Fedoric B; Krishnan R
    Immunol Lett; 2008 Oct; 120(1-2):49-56. PubMed ID: 18652845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on induction of dendritic cells from myeloid leukemia cell lines and their antitumor immune function].
    Luo YP; Li YG; Cai DC; Ren H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):229-35. PubMed ID: 12513792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway.
    Liang S; Ristich V; Arase H; Dausset J; Carosella ED; Horuzsko A
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8357-62. PubMed ID: 18550825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of CD4+ CD25+ Foxp3+ T regulatory cells by dendritic cells derived from ILT3 lentivirus-transduced human CD34+ cells.
    Ge G; Tian P; Liu H; Zheng J; Fan X; Ding C; Jin Z; Luo X; Xue W
    Transpl Immunol; 2012 Jan; 26(1):19-26. PubMed ID: 22005288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.
    Gregori S; Magnani CF; Roncarolo MG
    Hum Immunol; 2009 Dec; 70(12):966-9. PubMed ID: 19664675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation.
    Svajger U; Obermajer N; Jeras M
    Immunology; 2010 Apr; 129(4):525-35. PubMed ID: 20002210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells.
    Manavalan JS; Rossi PC; Vlad G; Piazza F; Yarilina A; Cortesini R; Mancini D; Suciu-Foca N
    Transpl Immunol; 2003; 11(3-4):245-58. PubMed ID: 12967778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells.
    Ristich V; Zhang W; Liang S; Horuzsko A
    Hum Immunol; 2007 Apr; 68(4):264-71. PubMed ID: 17400062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1.
    Apps R; Gardner L; Sharkey AM; Holmes N; Moffett A
    Eur J Immunol; 2007 Jul; 37(7):1924-37. PubMed ID: 17549736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
    LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
    FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G.
    Liang S; Horuzsko A
    Hum Immunol; 2003 Nov; 64(11):1025-32. PubMed ID: 14602231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.
    Wang Q; Sun B; Wang D; Ji Y; Kong Q; Wang G; Wang J; Zhao W; Jin L; Li H
    Scand J Immunol; 2008 Dec; 68(6):607-15. PubMed ID: 18959624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis.
    Summers KL; O'Donnell JL; Heiser A; Highton J; Hart DN
    Arthritis Rheum; 1999 Mar; 42(3):507-18. PubMed ID: 10088774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
    Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.